Open | - |
Close | - |
Volume / Avg. | 8.114K / 1.656M |
Day Range | - - - |
52 Wk Range | 16.040 - 32.000 |
Market Cap | $3.853B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | 6.3% |
Days to Cover | 5.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Insmed (NASDAQ: INSM) through any online brokerage.
Other companies in Insmed’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for Insmed (NASDAQ: INSM) was reported by Guggenheim on Tuesday, February 27, 2024. The analyst firm set a price target for 54.00 expecting INSM to rise to within 12 months (a possible 108.09% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Insmed (NASDAQ: INSM) is $25.95 last updated Today at March 19, 2024 at 8:23 AM EDT.
There are no upcoming dividends for Insmed.
Insmed’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.